Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
Cirtuvivint is a selective pan-CLK, pan-DYRK inhibitor that modulates alternative RNA splicing, including transcripts involved in oncogenic pathways. Preclinical studies have shown that CLK/DYRK ...
MedPage Today on MSN
The Ins and Outs of Respiratory Virus Vaccines for Immunocompromised Patients
For immunocompromised patients who've never had a COVID shot or only had an incomplete series, guidelines from the Advisory ...
Research suggests that a range of health factors that people can actually control may help to keep the brain from aging ...
New Jersey is poised to become one of the first states on the East Coast to establish a regulated framework for ...
Frank has been chief of the Department of Laboratory Medicine at the National Institutes of Health Clinical Center since 2018 ...
ROURKELA: The National Institute of Technology-Rourkela has secured two research projects under the Scheme for Promotion of Academic and Research Collaboration ...
New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and ...
The Texas Tech University School of Veterinary Medicine is creating its first food animal residency program. The program, backed by a $250,000 grant from the US Department of Agriculture (USDA), aims ...
Vaccine safety monitoring in the US is a multilayered process that combines passive and active functions, as well as expert ...
The center runs hundreds of clinical trials, supports five research programs, and 14 disease oriented teams, helping UTSW ...
Animal rights groups celebrate, but the Trump administration is light on specifics about phasing out federally funded medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results